Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy.

Saved in:
Bibliographic Details
Title: Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy.
Authors: Fallowfield, L, Gagnon, D, Zagari, M, Cella, D, Bresnahan, B, Littlewood, T J, McNulty, P, Gorzegno, G, Freund, M, Epoetin Alfa Study Group (CORPORATE AUTHOR)
Source: British Journal of Cancer. 12/2/2002, Vol. 87 Issue 12, p1341-1353. 13p.
Database: Academic Search Ultimate
Description
ISSN:00070920